CLINICAL EFFECTS OF SINGLE PILL COMBINATION THERAPY OF ANTIHYPERTENSIVES AND STATIN ON BLOOD PRESSURE, LIPID, AND CARDIOVASCULAR RISK PROFILES IN PATIENTS WITH NEWLY DIAGNOSED HYPE

被引：0
|
作者：
Park, Sang Min [1 ]
Cho, Eun Jeong [2 ]
机构：
[1] Eulji Univ, Med Ctr, Seoul, South Korea
[2] Chung Ang Univ, Med Ctr, Gwangmyeong, South Korea
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E143 / E143
页数：1
相关论文
共 50 条
  • [31] SWITCH TO PERINDOPRIL 10MG/INDAPAMIDE 2.5MG SINGLE-PILL COMBINATION IN HYPERTENSIVE DIABETIC PATIENTS WITH UNCONTROLLED BLOOD PRESSURE ON DUAL THERAPY: PERFORMANCE STUDY SUBANALYSIS
    Mourad, J.
    Schueller, R.
    Allaert, F. A.
    JOURNAL OF HYPERTENSION, 2017, 35 : E192 - E192
  • [32] Clinical utility of single-pill amlodipine besylate/atorvastatin calcium for the attainment of blood pressure and lipid goals in patients of diverse ethnicity with diabetes: Results from the GEMINI-AALA Study
    Aguilar-Salinas, C. A.
    Ro, Y.
    Tse, H.-F.
    Howes, L. G.
    Chaves, H.
    Erdine, S.
    Guindy, R.
    Chopra, P.
    Moller, R. A.
    Schou, I. M.
    DIABETOLOGIA, 2007, 50 : S478 - S478
  • [33] Chart review of patients receiving valsartan-amlodipine single-pill combination versus valsartan and amlodipine combination for blood pressure goal achievement and effects on the Hamilton anxiety rating/Hamilton depression rating scales
    Yin, Gang
    Li, Yuefan
    Xu, Wenjie
    Han, Na
    MEDICINE, 2019, 98 (51)
  • [34] Changes in weight and blood pressure as possible cardiovascular risk factors in patients with early rheumatoid arthritis after one year of initial combination therapy including prednisone or infliximab
    Van der Kooij, S. M.
    De Vries-Bouwstra, J. K.
    Goekoop-Ruiterman, Y. P. M.
    Van der Lubbe, P. A. H. M.
    Seys, P. E. H.
    Breedveld, F. C.
    Allaart, C. F.
    Dijkmans, B. A. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 492 - 492
  • [35] Effects of systolic blood pressure levels on risk for strokes in coronary artery disease patients receiving anti-thrombotic combination therapy: JCAD study
    Kai, H.
    Kohro, T.
    Kohro, T.
    Fukuda, K.
    Fukuda, K.
    Fukumoto, Y.
    Fukumoto, Y.
    Yamasaki, T.
    Yamasaki, T.
    Nagai, R.
    Nagai, R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 190 - 191
  • [36] Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk: The influence of baseline medication on LDL-cholesterol, blood pressure and calculated risk reduction when switching to a cardiovascular polypill
    Lafeber, Melvin
    Spiering, Wilko
    Visseren, Frank L. J.
    Grobbee, Diederick E.
    Bots, Michiel L.
    Stanton, Alice
    Patel, Anushka
    Prabhakaran, Dorairaj
    Webster, Ruth
    Thom, Simon
    Rodgers, Anthony
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (09) : 951 - 961
  • [37] Effects of Pioglitazone and Metformin Fixed-Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes
    Perez, Alfonso
    Jacks, Randal
    Arora, Vipin
    Spanheimer, Robert
    JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (12): : 973 - 982
  • [38] A CLINICAL SERVICE EVALUATION INVESTIGATING HOW LIPID, GLYCAEMIC AND BLOOD PRESSURE CONTROL IMPACTS THE LONG-TERM CARDIOVASCULAR OUTCOMES OF PATIENTS AT RISK OF RECURRENT ACUTE CORONARY SYNDROME
    Burgher, Tanisha
    James, Alexander
    Wong, Aaron
    HEART, 2022, 108 : A138 - A138
  • [39] Multiple-risk intervention with single-pill amlodipine/atorvastatin therapy helps patients with diverse ethnicity attain recommended therapeutic goals for blood pressure and lipids (the GEMINI-AALA study)
    Tse, Hung F.
    Ro, Young-Moo
    Howes, Laurie
    Aguilar-Salinas, Carlos
    Chaves, Hilton
    Erdine, Serap
    Guindy, Ramez
    Chopra, Pravin
    Moller, Robert A.
    Schou, I. Manjula
    JOURNAL OF HYPERTENSION, 2006, 24 : 329 - 329
  • [40] The Efficacy and Safety of the Combination Therapy of Decitabine, Venetoclax, and Selinexor (DVS) for Newly Diagnosed Unfit AML and MDS, and Relapsed/ Refractory AML and High-Risk MDS- a Multicenter, Single Arm, Prospective Clinical Study
    Xing, Lina
    Guo, Zijing
    Huang, Chen
    Jing, Hongmei
    Qiao, Shukai
    BLOOD, 2024, 144 : 6057 - 6058
12345